213 related articles for article (PubMed ID: 14307703)
21. [The structure and role of the sugar moiety of fibrinogen and fibrin: On the bonding of sugar compounds].
MESTER L; MOCZAR E; LAKI K
C R Hebd Seances Acad Sci; 1963 Jan; 256():307-8. PubMed ID: 13935150
[No Abstract] [Full Text] [Related]
22. [Possibility of interference of the fibrinogen-fibrin conversion mechanism by small doses of heparin].
SCANU A; MANCINI M
Boll Soc Ital Biol Sper; 1955; 31(1-2):148-51. PubMed ID: 13239848
[No Abstract] [Full Text] [Related]
23. The action of plasmin on fibrin and fibrinogen in blood.
MULLERTZ S
Acta Physiol Scand; 1953 Mar; 28(1):29-40. PubMed ID: 13065148
[No Abstract] [Full Text] [Related]
24. Phase changes and dimensional changes in fibrinogen and fibrin.
FERRY JD
J Cell Physiol Suppl; 1957 May; 49(Suppl 1):185-97. PubMed ID: 13449121
[No Abstract] [Full Text] [Related]
25. Electron microscopy of fibrinogen and fibrin.
HALL CE
J Biol Chem; 1949 Jun; 179(2):857-64. PubMed ID: 18150018
[No Abstract] [Full Text] [Related]
26. [BOVINE FIBRINOGEN IN FIBRIN PLATE METHOD FOR IDENTIFICATION OF HUMAN BLOOD STAIN].
MIKAMI Y; HABA K; TANAKA M; MORIOKA H
Nihon Hoigaku Zasshi; 1964 Jul; 18():308-14. PubMed ID: 14206009
[No Abstract] [Full Text] [Related]
27. [Effect of serum inhibitor on the esterase fibrino- and fibrinogenolytic activity of trypsin].
VEREMIENKO KN
Ukr Biokhim Zh; 1961; 33():667-75. PubMed ID: 13925416
[No Abstract] [Full Text] [Related]
28. [Marked fibrinolysis and fibrinogenelysis as possible pathogenetic consequences of immunitary phenomena in the organism].
ZARDI O
Rend Ist Sup Sanit; 1956; 19(4-5):437-48. PubMed ID: 13350604
[No Abstract] [Full Text] [Related]
29. Fibrinogen-fibrin conversion syndrome.
HODGKINSON CP
West J Surg Obstet Gynecol; 1956 Dec; 64(12):658-62. PubMed ID: 13381104
[No Abstract] [Full Text] [Related]
30. EFFECT OF PLASMIN ON FIBRINOGEN AND FIBRIN.
GAJEWSKI J; ALEXANDER B
Am J Physiol; 1964 Jan; 206():79-82. PubMed ID: 14111457
[No Abstract] [Full Text] [Related]
31. The conversion of fibrinogen to fibrin. IV. Reversible inhibition of the reaction.
SHULMAN S
Arch Biochem; 1951 Feb; 30(2):353-71. PubMed ID: 14811507
[No Abstract] [Full Text] [Related]
32. [Time of fibrinogen-fibrin conversion in normal blood clotting].
BRAUNSTEINER H; REIMER EE
Wien Z Inn Med; 1950 Oct; 31(10):375-7. PubMed ID: 14798856
[No Abstract] [Full Text] [Related]
33. [A method for microdetermination of fibrinogen in blood].
GEROK W
Hoppe Seylers Z Physiol Chem; 1952; 291(3):129-43. PubMed ID: 12999188
[No Abstract] [Full Text] [Related]
34. [The specificity of fibrinogen of mammals].
SZILAGYI T; BAGDY D; JAVOR T
Kiserl Orvostud; 1952 Aug; 4(4):262-7. PubMed ID: 13023856
[No Abstract] [Full Text] [Related]
35. THE BINDING OF HUMAN FIBRINOGEN TO NATIVE AND FRACTION FIBRINS AND THE INHIBITION OF POLYMERIZATION OF A NEW HUMAN FIBRIN MONOMER BY FIBRINOGEN.
COPLEY AL; LUCHINI BW
Life Sci (1962); 1964 Nov; 3():1293-305. PubMed ID: 14231779
[No Abstract] [Full Text] [Related]
36. Influence of dextran on the conversion of fibrinogen to fibrin.
LAURELL AB
Scand J Clin Lab Invest; 1951; 3(4):262-6. PubMed ID: 14900980
[No Abstract] [Full Text] [Related]
37. The conversion of fibrinogen to fibrin. III. Sedimentation and viscosity studies on clotting systems inhibited by hexamethylene glycol.
SHULMAN S; FERRY JD
J Phys Colloid Chem; 1951 Jan; 55(1):135-44. PubMed ID: 14814639
[No Abstract] [Full Text] [Related]
38. Electron microscope observations on intermediate polymers in the conversion of fibrinogen to fibrin.
KAESBERG P; SHULMAN S
J Biol Chem; 1953 Jan; 200(1):293-6. PubMed ID: 13034785
[No Abstract] [Full Text] [Related]
39. FIBRINOGEN BREAKDOWN PRODUCTS.
LEWIS JH; WILSON JH
Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
[No Abstract] [Full Text] [Related]
40. [A new and simple colorimetric method for the determination of fibrinogen].
MARENZI AD; GOMEZ CJ
Bull Soc Chim Biol (Paris); 1951; 33(3-4):409-12. PubMed ID: 14935612
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
